[1]
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71: 2199-269.
[2]
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 33: 3021-104.
[3]
Kario K. Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A perspective from Japan. Circulation 2018; 137: 543-5.
[4]
Shimamoto K, Ando K, Fujita T, et al. Japanese Society of Hypertension Committee for Guidelines for the Management of H. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253-390.
[5]
Kario K, Thijs L, Staessen JA. Blood pressure measurement and treatment decisions: Masked and white coat hypertension. Circ Res 2018 in press
[6]
Pierdomenico SD, Pierdomenico AM, Coccina F, et al. Prognostic value of masked uncontrolled hypertension. Hypertension 2018; 72: 862-9.
[7]
Fujiwara T, Yano Y, Hoshide S, Kanegae H, Kario K. Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a Japanese ceneral practice population. JAMA Cardiol 2018; 3: 583-90.
[8]
Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med 2018; 378: 1509-20.
[9]
Verdecchia P, Reboldi GP, Angeli F, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45: 203-8.
[10]
Kario K, Pickering TG. White-coat hypertension or white-cost hypertension syndrome: Which is accompanied by target organ damage? Arch Intern Med 2000; 160: 3497-8.
[11]
Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-5.
[12]
Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: Primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 2014; 64: 989-96.
[13]
Kario K, Saito I, Kushiro T, et al. Morning home blood pressure is a strong predictor of coronary artery disease: The HONEST study. J Am Coll Cardiol 2016; 67: 1519-27.
[14]
Hoshide S, Yano Y, Haimoto H, et al. morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the japanese general practice population: The Japan morning surge-home blood pressure study. Hypertension 2016; 68: 54-61.
[15]
Kario K, Iwashita M, Okuda Y, et al. Morning home blood pressure and cardiovascular events in Japanese hypertensive patients. Hypertension 2018; 72: 854-61.
[16]
Chia YC, Buranakitjaroen P, Chen CH, et al. HOPE Asia Network,Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network. J Clin Hypertens 2017; 19: 1192-201.
[17]
Park S, Buranakitjaroen P, Chen CH, et al. HOPE Asia Network,Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network. J Hum Hypertens 2018; 32: 249-58.
[18]
Kario K, Park S, Buranakitjaroen P, et al. Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network. J Clin Hypertens 2018; 20: 456-61.
[19]
Kario K, Chen CH, Park S, et al. Consensus document on improving hypertension management in Asian patients, taking into account asian characteristics. Hypertension 2018; 71: 375-82.
[20]
Kario K, Tomitani N, Buranakitjaroen P, et al. HOPE Asia Network,Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regions. J Clin Hypertens 2018; 20: 33-8.
[21]
Kario K, Tomitani N, Buranakitjaroen P, et al. on behalf of the HOPE Asia Network,Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study. J Clin Hypertens 2018; 20: 1686-95.
[22]
Hanazawa T, Asayama K, Watabe D, et al. HOMED-BP (Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure) Investigators. Association between amplitude of seasonal variation in self-measured home blood pressure and cardiovascular outcomes: HOMED-BP (Hypertension Objective Treatment Based on Measurement By Electrical Devices of Blood Pressure) study. J Am Heart Assoc 2018; 7(10): e008509.
[23]
Nishizawa M, Hoshide S, Okawara Y, Matsuo T, Kario K. Strict blood pressure control achieved using an ICT-based home blood pressure monitoring system in a catastrophically damaged area after a disaster. J Clin Hypertens 2017; 19: 26-9.
[24]
Nishizawa M, Fujiwara T, Hoshide S, et al. Winter morning surge in blood pressure after the Great East Japan Earthquake. J Clin Hypertens 2019 in press
[25]
Kario K. Differential approaches are much needed for “Real world” management of hypertension in the era of “Hypertension paradox”. Curr Hypertens Rev 2018; 14: 2-5.
[26]
Kario K, Wang JG. Could 130/80 mm Hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension 2018; 71: 979-84.
[27]
Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003; 107: 1401-6.
[28]
Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852-7.
[29]
Kario K. Evidence and Perspectives on the 24-hour management of hypertension: Hemodynamic biomarker-initiated ‘anticipation medicine’ for Zero cardiovascular event. Prog Cardiovasc Dis 2016; 59: 262-81.
[30]
Kuwabara M, Kario K. Development of a triggered nocturnal blood pressure monitoring which detects nighttime blood pressure surges in sleep apnea syndrome. Curr Hypertens Rev 2016; 12: 27-31.
[31]
Kario K. Hemodynamic biomarker-initiated anticipation medicine in the future management of hypertension. Am J Hypertens 2017; 30: 226-8.
[32]
Kuwabara M, Hamasaki H, Tomitani N, Shiga T, Kario K. Novel triggered nocturnal blood pressure monitoring for sleep apnea syndrome: Distribution and reproducibility of hypoxia-triggered nocturnal blood pressure measurements. J Clin Hypertens (Greenwich) 2017; 19: 30-7.
[33]
Kuwabara M, Tomitani N, Shiga T, Kario K. Polysomnography-derived sleep parameters as a determinant of nocturnal blood pressure profile in patients with obstructive sleep apnea. J Clin Hypertens Greenwich 2018; 20: 1039-48.
[34]
Sasaki N, Nagai M, Mizuno H, Kuwabara M, Hoshide S, Kario K. Associations between characteristics of cbstructive sleep apnea and nocturnal blood pressure surge. Hypertension 2018; 72: 1133-40.
[36]
Kario K. Essential manual on perfect 24-hour blood pressure management from morning to nocturnal hypertension: Up-to-date for anticipation medicine. Wiley-Blackwell: Tokyo, Japan 2018; pp. 1-309. 2018
[37]
Kario K. New insight of morning blood pressure surge into the triggers of cardiovascular disease-synergistic resonance of blood pressure variability. Am J Hypertens 2016; 29: 14-6.
[38]
Kario K, Tomitani N, Kanegae H, et al. Development of a new ICT-based multisensor blood pressure monitoring system for use in hemodynamic biomarker-initiated anticipation medicine for cardiovascular disease: The National IMPACT Program Project. Prog Cardiovasc Dis 2017; 60: 435-49.
[39]
Impulsing Paradigm Change through Disruptive Technologies
Program (ImPACT): “An Ultra Big Data Platform for Reducing
Social Risks”. Predictive health care realized by using ultra-big data
with connected medical devices [movie; MP4]. http://www. jichi.ac.jp/usr/card/research/index_en.html
Article Metrics
50
9